MedTrace Logo

Activating SilverSneakers Benefits for Seniors With Osteoarthritis

NCT06782347 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1454

Last updated 2026-02-10

No results posted yet for this study

Summary

The aim of this pragmatic randomized controlled trial is to test the effects of a brief proactive care intervention involving mailed material and two phone calls on: (1) increasing participation in SilverSneakers exercise programs among older adults with osteoarthritis; (2) improving physical, social and psychological outcomes identified as important to older adults with osteoarthritis; and (3) reducing costly osteoarthritis-related health service use. Approximately 1,454 older adults with osteoarthritis who have SilverSneakers access through their Medicare Advantage plan, but no prior SilverSneakers use, will be recruited to participate across the United States. Key outcome measures will be assessed over a two-year follow-up period.

Conditions

Interventions

BEHAVIORAL

Proactive Care

The proactive care intervention was designed to be similar to proactive care approaches used successfully in the tobacco control area. These proactive care procedures have not yet been adequately evaluated in the exercise promotion area.

Sponsors & Collaborators

  • Humana Healthcare Research

    collaborator UNKNOWN

  • Kaiser Permanente

    collaborator OTHER

  • Global Healthy Living Foundation

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • CVS Healthspire Life Sciences Solutions

    collaborator UNKNOWN

  • Tivity Health

    collaborator UNKNOWN

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Liza S. Rovniak, PhD, MPH · Penn State College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-21
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06782347 on ClinicalTrials.gov